Trabectedin - Latest Advances

DCMiC: a double-cylinder micro-chamber platform for high-throughput drug screening and modeling of microenvironmental resistance in Ewing sarcoma.

Journal: Lab on a chip

Published: December 09, 2025

Trabectedin-irinotecan as a potential therapeutic option in desmoplastic small round cell tumor: A small case series.

Journal: Tumori

Published: November 10, 2025

Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase 2 study from the Italian Sarcoma Group.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 24, 2025

Chemotherapy Strategies and Their Efficacy for Mesenchymal Chondrosarcoma.

Journal: Current oncology (Toronto, Ont.)

Published: September 05, 2025

Use of doxorubicin and trabectedin in low-grade endometrial stromal sarcoma: A case report.

Journal: Gynecologic oncology reports

Published: August 29, 2025

Advances in tumor-associated macrophage-mediated chemotherapeutic resistance in glioma.

Journal: Frontiers in cell and developmental biology

Published: July 30, 2025

The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic Cholangiocarcinoma.

Journal: International journal of molecular sciences

Published: July 18, 2025

Excellent Response and Persistent Local Control of Metastatic Extraskeletal Myxoid Chondrosarcoma Repeatedly Treated with Surgical Excision or Stereotactic Radiotherapy Alone: A Case Report.

Journal: Case reports in oncology

Published: July 04, 2025

Maintenance after first-line treatment for advanced soft tissue sarcoma.

Journal: Critical reviews in oncology/hematology

Published: June 26, 2025

Maintenance therapy-a potential strategy to prolong the survival of advanced soft tissue sarcoma patients.

Journal: Therapeutic advances in medical oncology

Published: May 20, 2025

Multimodal treatment with cisplatin for metastatic disease in malignant peripheral nerve sheath tumors: a case report and review.

Journal: Anti-cancer drugs

Published: May 06, 2025

Correction: Povo-Retana et al. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment-Progresses in Their Use in Combined Cancer Therapy. Molecules 2024, 29, 331.

Journal: Molecules (Basel, Switzerland)

Published: April 16, 2025

Filters

DCMiC: a double-cylinder micro-chamber platform for high-throughput drug screening and modeling of microenvironmental resistance in Ewing sarcoma.

DCMiC: a double-cylinder micro-chamber platform for high-throughput drug screening and modeling of microenvironmental resistance in Ewing sarcoma.

Trabectedin-irinotecan as a potential therapeutic option in desmoplastic small round cell tumor: A small case series.

Trabectedin-irinotecan as a potential therapeutic option in desmoplastic small round cell tumor: A small case series.

Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase 2 study from the Italian Sarcoma Group.

Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase 2 study from the Italian Sarcoma Group.

Chemotherapy Strategies and Their Efficacy for Mesenchymal Chondrosarcoma.

Chemotherapy Strategies and Their Efficacy for Mesenchymal Chondrosarcoma.

Use of doxorubicin and trabectedin in low-grade endometrial stromal sarcoma: A case report.

Use of doxorubicin and trabectedin in low-grade endometrial stromal sarcoma: A case report.

Advances in tumor-associated macrophage-mediated chemotherapeutic resistance in glioma.

Advances in tumor-associated macrophage-mediated chemotherapeutic resistance in glioma.

The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic Cholangiocarcinoma.

The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic Cholangiocarcinoma.

Excellent Response and Persistent Local Control of Metastatic Extraskeletal Myxoid Chondrosarcoma Repeatedly Treated with Surgical Excision or Stereotactic Radiotherapy Alone: A Case Report.

Excellent Response and Persistent Local Control of Metastatic Extraskeletal Myxoid Chondrosarcoma Repeatedly Treated with Surgical Excision or Stereotactic Radiotherapy Alone: A Case Report.

Maintenance after first-line treatment for advanced soft tissue sarcoma.

Maintenance after first-line treatment for advanced soft tissue sarcoma.

Maintenance therapy-a potential strategy to prolong the survival of advanced soft tissue sarcoma patients.

Maintenance therapy-a potential strategy to prolong the survival of advanced soft tissue sarcoma patients.

Multimodal treatment with cisplatin for metastatic disease in malignant peripheral nerve sheath tumors: a case report and review.

Multimodal treatment with cisplatin for metastatic disease in malignant peripheral nerve sheath tumors: a case report and review.

Correction: Povo-Retana et al. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment-Progresses in Their Use in Combined Cancer Therapy. Molecules 2024, 29, 331.

Correction: Povo-Retana et al. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment-Progresses in Their Use in Combined Cancer Therapy. Molecules 2024, 29, 331.